Longitudinal Study of Intra-Uterine Growth Restriction
NCT02382601 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-02-13
Summary
The investigation will employ a longitudinal approach in which every fetus diagnosed to be SGA (Small for Gestational Age ) will be studied at frequent intervals with sophisticated imaging techniques to assess subtle physiologic changes in the brain, heart, and placenta over time. These findings will be correlated with neurological and cardiovascular function in the newborn and early childhood. This research initiative should yield diagnostic and therapeutic templates that will improve the quality of life of IUGR babies in addition to providing important information that will better inform current diagnostic practices.
Conditions
- IUGR
- Pregnancy
Interventions
- RADIATION
-
Ultrasound
With 3-D and 4-D high-resolution color Doppler methods it is possible to map out the placental circulation, fetal circulation, fetal brain, and fetal cardiac function. Investigators will collect these data points prenatally.
- RADIATION
-
MRI
Similar to the Ultrasound data, investigators will collect MRI images of the fetal brain and the placenta. MRI will allow investigators to collect more detailed images of both the fetal brain and placenta, and investigators will be utilizing this technique both prenatally and postnatally.
- PROCEDURE
-
Blood collection
The maternal and cord blood will be collected for the processing of plasma and serum. There may be early biomarkers of IUGR in the maternal circulation that investigators can use to better determine the appropriate strategy for clinical management of care. Collection and subsequent analysis of molecular markers in the umbilical cord blood will be used to further confirm physiological dysfunction as detected by ultrasound and MRI techniques.
- BEHAVIORAL
-
Neurological Function Assessment
Neurological development tests including a Bayley exam, Mullen exam, Developmental Profile-3, Child Behavior Checklist, and Pediatric Stroke Outcome Measure (PSOM) will be performed.
- PROCEDURE
-
Placental Analysis
Placentas will undergo pathological evaluation for placental function.
- PROCEDURE
-
Measurement of body fat
The baby's body fat will be measured in a special incubator called a PEAPOD or BODPOD when an infant.
- RADIATION
-
Pediatric heart ultrasound
Children will have ultrasounds of their hearts during follow-up visits.
Sponsors & Collaborators
-
The Perelman Family Foundation
collaborator UNKNOWN -
University of Colorado, Denver
lead OTHER
Principal Investigators
-
John Hobbins, MD · University of Colorado, Denver
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
Study of the Physiology of Pre-eclampsia and Vascular IUGR With Constitution of a Biological Collection
NCT03626233 ·Status: UNKNOWN
-
Thromboelastography (TEG) In the Intrauterine Growth Restriction (IUGR) Neonatal Population by Gestational Age
NCT04907578 ·Status: WITHDRAWN
-
Predicting Placental Pathologies by Ultrasound Imaging
NCT04506970 ·Status: COMPLETED
-
Leukemia Inhibitory Factor Level in Intrauterine Growth Restriction Neonates
NCT02518126 ·Status: UNKNOWN
-
Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.
NCT01995968 ·Status: UNKNOWN
-
Is Serum YKL-40 Capable of Predicting Intrauterine Growth Restriction (IUGR) and Preeclampsia?
NCT00836524 ·Status: UNKNOWN
-
Routine Ultrasound Screening in the Third Trimester
NCT01594463 ·Status: COMPLETED ·Phase: NA
-
Pre-Eclampsia And Growth Restriction: a Longitudinal Study
NCT02379832 ·Status: COMPLETED
-
Maternal Left Lateral Position in Fetal Growth Restriction
NCT06919692 ·Status: RECRUITING ·Phase: NA
-
CGH-array in Prenatal Diagnosis of Isolated Severe and Early Intra-uterine Growth Restriction
NCT04729361 ·Status: UNKNOWN
-
Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Retardation: A Longtitudinal Study
NCT00340899 ·Status: COMPLETED
-
Utero-placental Vascularisation in Normal and Preeclamptic and Intra-uterine Growth Restriction Pregnancies
NCT02825277 ·Status: UNKNOWN ·Phase: NA
-
Study of Placental Vascularization Using Contrast Ultrasound
NCT06497959 ·Status: RECRUITING ·Phase: PHASE3
-
Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women
NCT05622838 ·Status: UNKNOWN
-
Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn
NCT01648855 ·Status: COMPLETED
-
Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction
NCT02672566 ·Status: COMPLETED ·Phase: PHASE3
-
EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction
NCT01490489 ·Status: COMPLETED ·Phase: NA
-
The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study
NCT06517628 ·Status: RECRUITING
-
Minimally-invasive Assessment of Cardiac Output in Severe Preeclampsia
NCT00465114 ·Status: WITHDRAWN
-
Fetal Growth Restriction: Management Using Two Guidelines - Fetal Growth Antenatal Management Evaluation
NCT05938829 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A First Trimester Prediction Model for Large for Gestational Age Infants: a Preliminary Study
NCT04838431 ·Status: TERMINATED
-
First-trimester Prediction of Preeclampsia
NCT02189148 ·Status: COMPLETED
-
EVERREST Developing a Therapy for Fetal Growth Restriction
NCT02097667 ·Status: COMPLETED
-
Effects of Serial Plotting on Fundal Height Charts on Identification and Outcomes of Small for Gestational Age Infants
NCT02964793 ·Status: UNKNOWN ·Phase: NA
-
Cord Blood S100B Protein Concentration in Neonates With Fetal Growth Restriction
NCT06893926 ·Status: RECRUITING